Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Receivables - Net: 2014-2021

Historic Receivables - Net for Agios Pharmaceuticals (AGIO) over the last 7 years, with Dec 2021 value amounting to $4.4 million.

  • Agios Pharmaceuticals' Receivables - Net was N/A to $4.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $4.4 million, marking a year-over-year change of. This contributed to the annual value of $4.4 million for FY2021, which is N/A change from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Receivables - Net of $4.4 million as of FY2021, which was up 184.47% from $1.5 million recorded in FY2019.
  • In the past 5 years, Agios Pharmaceuticals' Receivables - Net registered a high of $4.4 million during FY2021, and its lowest value of $1.5 million during FY2019.
  • Its 2-year average for Receivables - Net is $3.0 million, with a median of $3.0 million in 2019.
  • Per our database at Business Quant, Agios Pharmaceuticals' Receivables - Net tumbled by 49.90% in 2017 and then rose by 0.57% in 2018.
  • Over the past 4 years, Agios Pharmaceuticals' Receivables - Net (Yearly) stood at $2.4 million in 2017, then climbed by 0.57% to $2.5 million in 2018, then tumbled by 37.49% to $1.5 million in 2019, then reached $4.4 million in 2021.